Skip to main content
Clinical Trials/NCT05075486
NCT05075486
Withdrawn
Not Applicable

Collaborative Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support in China

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Life Support
Sponsor
Children's Hospital of Fudan University
Primary Endpoint
Mortality or severe intracranial hemorrhage (ICH) before discharge
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

This is a three-year pre- and post- interventional study to assess the effectiveness of collaborative quality improvement interventions on reducing mortality and severe intracranial hemorrhage (ICH) for neonates receiving extracorporeal life support (ECLS) in China.

Detailed Description

This is a three-year pre- and post- interventional study from 2022 to 2024. The population of this study will be all neonates who receive ECLS support within 28 days of life in the participating hospitals of Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS). The intervention will be collaborative quality improvement interventions for each of the participating hospital. Detailed interventions include standardized ECLS data feedback and benchmark, establishment of potential better practice list, training on quality improvement, implementation of practice change using plan-do-study-action cycles, report and monitor of practice change and collaborative learning. The first year will be pre-intervention baseline period and serves as the control period. Collaborative quality improvement interventions will be introduced from the start of the second year and the second and third years will be the intervention period. The primary outcome, which is the incidence of mortality or severe ICH of the third year, will be compared to that of the baseline year.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≤28 days of life
  • receive ECLS support

Exclusion Criteria

  • Infants with severe congenital anomalies
  • Infants with pre-ECLS ICH

Outcomes

Primary Outcomes

Mortality or severe intracranial hemorrhage (ICH) before discharge

Time Frame: From admission to discharge or death, an average of 3 months

It is a binary variable (1/0). The variable would be set into "1", if death or severe ICH occurred

Secondary Outcomes

  • Incidence of severe ICH(From admission to discharge or death, an average of 3 months)
  • Incidence of successful decannulation of extracorporeal life support(From admission to discharge or death, an average of 3 months)
  • Mortality(From admission to discharge or death, an average of 3 months)
  • Incidences of ECLS related complications(From admission to discharge or death, an average of 3 months)

Similar Trials